Peptide Synthesis Market Primary & Secondary Research, Projection, Segmentation, Trends and Forecast by 2028

The global peptide synthesis market size is expected to reach USD 516.75 Million by 2028 and register a revenue CAGR of 6.4% over the forecast period, according to latest analysis by Reports and Data.

The Global Peptide Synthesis Market size is expected to reach USD 516.75 Million by 2028 and register a revenue CAGR of 6.4% over the forecast period, according to latest analysis by Reports and Data. Major factors driving market revenue growth are increasing use of peptides in pharmaceutical drugs, rise in research activities and availability of funding for RD, and development of advanced technological peptide synthesizers.

Peptides are highly specific and effective signalling molecules that bind to specific cell surface receptors such as G protein-coupled receptors (GPCRs) or ion channels, causing intracellular effects. Peptides are an excellent starting point for the development of novel therapeutics due to their excellent pharmacological profile and intrinsic properties. In humans, their specificity has been shown to translate into high levels of protection, tolerability, and efficacy.

Peptide therapeutics have a lower processing complexity than protein-based biopharmaceuticals, resulting in lower manufacturing costs that are similar to those of small molecules. As peptides strike a balance between small molecules and biopharmaceuticals, the peptide synthesis market has seen a large rise in revenue.

In addition to conventional peptide design, a number of peptide technologies have emerged that indicate high potential growth opportunities in the peptide synthesis industry. Among them are multifunctional and cell penetrating peptides, peptide drug conjugates, and innovations focused on different routes of administration.

Peptides have a wide range of applications, ranging from medicine and biotechnology, to therapeutic peptide chemistry in the last decade. Use of peptide for commercial purposes is also on the rise, which is also propelling peptide synthesis market growth. Lupron, which is a peptide-based drug used to treat prostate cancer and other diseases, had global sales of more than USD 752 million in 2020. In addition, sales for Sanofi's Lantus reached USD 7 billion in 2017. Approximately 140 peptide drugs are in clinical trials and over 500 therapeutic peptides in preclinical processing, and are currently more than 80 FDA-approved peptide medicines are on the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4007

Key market players analyzed in the report are:

Genscript Biotech, Merck KGaA, Aapptec, Bachem Holdings, Anaspec, Biotage, CEM Corporation, Gyros Protein Technologies, Advanced Chemtech, and NEP (New England Peptide).

Current peptide synthesis, on the other hand, is primarily focused on legacy technologies that use large amounts of highly volatile reagents and solvents. Lower performance, costly biocatalysts, and a lack of validation protocols are drawbacks of this technology, making peptide production by enzymatic methods difficult.

Some Key Highlights From the Report:

  • In 2020, reagents segment accounted for largest share among other product segments in the global peptide synthesis market.
  • The solid-phase synthesis segment is expected to register highest revenue CAGR during the forecast period.
  • In 2020, pharmaceutical biotechnological companies segment accounted for largest revenue share owing to increasing number of RD projects in genomics, molecular biology, and related fields.
  • North America accounted for largest revenue share in the global market in 2020. This can be attributed to major presence of key market players, increased availability of peptide synthesis technologies, as well as rising focus on producing peptide-based drugs on commercial scale.
  • The peptide synthesis market in Asia Pacific is expected to continue to register fastest revenue growth rate owing to increased investments by pharmaceutical and biotechnology companies as well as increasing RD activities in countries in the region.
  • Some major players in the global peptide synthesis market include Genscript Biotech, Merck KGaA, Aapptec, Bachem Holdings, Anaspec, Biotage, CEM Corporation, Gyros Protein Technologies, Advanced Chemtech, and NEP (New England Peptide).

To know more about the report @ https://www.reportsanddata.com/report-detail/peptide-synthesis-market

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global peptide synthesis market on the basis of product, technology, end use, and region:
Product Outlook (Revenue, USD Million; 2018 – 2028)

  • Reagents
  • Equipment
  • Peptide Synthesizers
  • Chromatography Equipment
  • Lyophilizers

Technology Outlook (Revenue, USD Million; 2018 – 2028)

  • Solid-phase Peptide Synthesis
  • Liquid-phase Peptide Synthesis
  • Hybrid Recombinant Technology

End User Outlook (Revenue, USD Million; 2018 – 2028)

  • Pharmaceutical and Biotechnology Companies 
  • Contract Development and Manufacturing Organizations
  • Academic and Research Institutes

Regional Outlook (Revenue, USD Million; 2018 – 2028)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East Africa

Key Question Addressed in the Report:

  • What are the key driving factors of the Peptide Synthesis industry?
  • What will the market size and growth rate be throughout the forecast period?
  • Who are the prominent players of the Peptide Synthesis industry?
  • What are the technological advancements and product developments taking place in the Peptide Synthesis market?
  • What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?
  • Which region is expected to dominate the market in the coming years?
  • What are the key risk factors and challenges the companies will face in the market?

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4007

Table of Content:

Chapter 1. Market Introduction
           1.1. Objectives of the Study 
           1.2. Market Definition 
           1.3. Market Scope 
                   1.3.1. Years Considered for the Study
                   1.3.2. Market Covered
           1.4. Currency 
           1.5. Limitations 
           1.6. Stakeholders 
Chapter 2.  Research Methodology 
           2.1. Research Data 
                   2.1.1. Secondary Data
                           2.1.1.1. Key Data from Secondary Sources
                   2.1.2. Primary Data
                            2.1.2.1. Key Data from Primary Sources
           2.2. Market Size Estimation 
           2.3. Market Breakdown and Data Triangulation 
           2.4. Assumptions for the Study
Chapter 3. Executive Summary
           3.1. Market Outlook
           3.2. Segment Outlook
           3.3. Competitive Insights
Chapter 4. Global Peptide Synthesis Market Variables, Trends Scope
           4.1. Market Lineage Outlook
           4.2. Penetration and Growth Prospect Mapping
           4.3. Industry Value Chain Analysis
           4.4. Cost Analysis Breakdown
           4.5. Technology Overview
           4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
Chapter 5. Global Peptide Synthesis Market Overview

Continued….

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.


marycyrus

31 Blog posts

Comments